Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Pfizer characterizes new antipsychotic agent

April 17, 1997

Pfizer describes substance P antagonists

April 17, 1997

Excitatory amino acid antagonists from Novartis

April 17, 1997

Pharmacia & Upjohn describes agents for 5-HT1A receptor-mediated disorders

April 17, 1997

SKB describes 5-HT2C/5-HT2B antagonists

April 17, 1997

5-HT2 antagonists/5-HT reuptake inhibitors described by Yamanouchi

April 16, 1997

Nasal midazolam safe and effective for anterograde amnesia in children undergoing VCUG

April 15, 1997

DuPont Merck reports orally active acetylcholine release enhancer

April 15, 1997

Novel dopamine receptor ligands from Purdue Research Foundation/UNC

April 15, 1997

ICE and apoptosis inhibitors disclosed by SmithKline Beecham

April 15, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...